Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.
Andrea Kuhnl, MD, King’s College Hospital, London, United Kingdom, discusses the impact of CAR T-cell therapy on the treatment of lymphoma patients in the UK as well as potential pitfalls associated with their use. This interview was recorded via an online conference call with The Video Journal of Hematological Oncology (VJHemOnc).
We use cookies to provide the best experience on our website. We also use third party cookies to collect analytical data and better improve our marketing strategies. If you continue to use this site you are consenting to the use of these cookies. For more information view our Cookie Policy.